Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

Researchers describe a concentric supraparticle system that protects and delivers RNA therapeutics for gene silencing in ...

Many leading pharma and biotechs have invested in messenger RNA (mRNA) technology to develop COVID-19 vaccines and are now exploring their potential in other disease areas (Figure 1). The success ...

The Boehringer Ingelheim Foundation is providing 600,000 Euros in funding for basic research into new approaches to the treatment of liver fibrosis and fatty liver hepatitis.

Yra1, other mRNA-binding proteins, the cap-binding proteins Cbp20 and Cbp80, and the poly(A) + RNA-binding protein Pab1 may jointly package mRNAs into an exportable configuration. After pre-mRNA ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...